The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors

Mei R. Fu, Constance M. Chen, Judith Haber, Amber A. Guth, Deborah Axelrod

Research output: Contribution to journalArticle

Abstract

Background. Despite recent advances in breast cancer treatment, breast cancer related lymphedema (BCRL) continues to be a significant problem for many survivors. Some BCRL risk factors may be largely unavoidable, such as mastectomy, axillary lymph node dissection (ALND), or radiation therapy. Potentially avoidable risk factors unrelated to breast cancer treatment include minor upper extremity infections, injury or trauma to the arm, overuse of the limb, and air travel. This study investigates how providing information about BCRL affects the cognitive and symptomatic outcome of breast cancer survivors. Methods. Data were collected from 136 breast cancer survivors using a Demographic and Medical Information interview instrument, a Lymphedema Education Status interview instrument, a Knowledge Test for cognitive outcome, and the Lymphedema and Breast Cancer Questionnaire for symptom outcome. Data analysis included descriptive statistics, t tests, chi-square (χ2) tests, and regression. Results. BCRL information was given to 57% of subjects during treatment. The mean number of lymphedema-related symptoms was 3 symptoms. Patients who received information reported significantly fewer symptoms and scored significantly higher in the knowledge test. After controlling for confounding factors, patient education remains an additional predictor of BCRL outcome. Significantly fewer women who received information about BCRL reported swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling. Conclusions. Breast cancer survivors who received information about BCRL had significantly reduced symptoms and increased knowledge about BCRL. In clinical practice, breast cancer survivors should be engaged in supportive dialogues so they can be educated about ways to reduce their risk of developing BCRL.

Original languageEnglish (US)
Pages (from-to)1847-1853
Number of pages7
JournalAnnals of Surgical Oncology
Volume17
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Neurobehavioral Manifestations
Lymphedema
Survivors
Breast Neoplasms
Air Travel
Breast Cancer Lymphedema
Interviews
Seroma
Mastectomy
Wounds and Injuries
Patient Education
Chi-Square Distribution
Lymph Node Excision
Upper Extremity
Breast
Arm
Radiotherapy
Therapeutics
Extremities
Demography

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Medicine(all)

Cite this

The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. / Fu, Mei R.; Chen, Constance M.; Haber, Judith; Guth, Amber A.; Axelrod, Deborah.

In: Annals of Surgical Oncology, Vol. 17, No. 7, 07.2010, p. 1847-1853.

Research output: Contribution to journalArticle

@article{e33804ee639f4f8aa126c78e621f1de3,
title = "The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors",
abstract = "Background. Despite recent advances in breast cancer treatment, breast cancer related lymphedema (BCRL) continues to be a significant problem for many survivors. Some BCRL risk factors may be largely unavoidable, such as mastectomy, axillary lymph node dissection (ALND), or radiation therapy. Potentially avoidable risk factors unrelated to breast cancer treatment include minor upper extremity infections, injury or trauma to the arm, overuse of the limb, and air travel. This study investigates how providing information about BCRL affects the cognitive and symptomatic outcome of breast cancer survivors. Methods. Data were collected from 136 breast cancer survivors using a Demographic and Medical Information interview instrument, a Lymphedema Education Status interview instrument, a Knowledge Test for cognitive outcome, and the Lymphedema and Breast Cancer Questionnaire for symptom outcome. Data analysis included descriptive statistics, t tests, chi-square (χ2) tests, and regression. Results. BCRL information was given to 57{\%} of subjects during treatment. The mean number of lymphedema-related symptoms was 3 symptoms. Patients who received information reported significantly fewer symptoms and scored significantly higher in the knowledge test. After controlling for confounding factors, patient education remains an additional predictor of BCRL outcome. Significantly fewer women who received information about BCRL reported swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling. Conclusions. Breast cancer survivors who received information about BCRL had significantly reduced symptoms and increased knowledge about BCRL. In clinical practice, breast cancer survivors should be engaged in supportive dialogues so they can be educated about ways to reduce their risk of developing BCRL.",
author = "Fu, {Mei R.} and Chen, {Constance M.} and Judith Haber and Guth, {Amber A.} and Deborah Axelrod",
year = "2010",
month = "7",
doi = "10.1245/s10434-010-0941-3",
language = "English (US)",
volume = "17",
pages = "1847--1853",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors

AU - Fu, Mei R.

AU - Chen, Constance M.

AU - Haber, Judith

AU - Guth, Amber A.

AU - Axelrod, Deborah

PY - 2010/7

Y1 - 2010/7

N2 - Background. Despite recent advances in breast cancer treatment, breast cancer related lymphedema (BCRL) continues to be a significant problem for many survivors. Some BCRL risk factors may be largely unavoidable, such as mastectomy, axillary lymph node dissection (ALND), or radiation therapy. Potentially avoidable risk factors unrelated to breast cancer treatment include minor upper extremity infections, injury or trauma to the arm, overuse of the limb, and air travel. This study investigates how providing information about BCRL affects the cognitive and symptomatic outcome of breast cancer survivors. Methods. Data were collected from 136 breast cancer survivors using a Demographic and Medical Information interview instrument, a Lymphedema Education Status interview instrument, a Knowledge Test for cognitive outcome, and the Lymphedema and Breast Cancer Questionnaire for symptom outcome. Data analysis included descriptive statistics, t tests, chi-square (χ2) tests, and regression. Results. BCRL information was given to 57% of subjects during treatment. The mean number of lymphedema-related symptoms was 3 symptoms. Patients who received information reported significantly fewer symptoms and scored significantly higher in the knowledge test. After controlling for confounding factors, patient education remains an additional predictor of BCRL outcome. Significantly fewer women who received information about BCRL reported swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling. Conclusions. Breast cancer survivors who received information about BCRL had significantly reduced symptoms and increased knowledge about BCRL. In clinical practice, breast cancer survivors should be engaged in supportive dialogues so they can be educated about ways to reduce their risk of developing BCRL.

AB - Background. Despite recent advances in breast cancer treatment, breast cancer related lymphedema (BCRL) continues to be a significant problem for many survivors. Some BCRL risk factors may be largely unavoidable, such as mastectomy, axillary lymph node dissection (ALND), or radiation therapy. Potentially avoidable risk factors unrelated to breast cancer treatment include minor upper extremity infections, injury or trauma to the arm, overuse of the limb, and air travel. This study investigates how providing information about BCRL affects the cognitive and symptomatic outcome of breast cancer survivors. Methods. Data were collected from 136 breast cancer survivors using a Demographic and Medical Information interview instrument, a Lymphedema Education Status interview instrument, a Knowledge Test for cognitive outcome, and the Lymphedema and Breast Cancer Questionnaire for symptom outcome. Data analysis included descriptive statistics, t tests, chi-square (χ2) tests, and regression. Results. BCRL information was given to 57% of subjects during treatment. The mean number of lymphedema-related symptoms was 3 symptoms. Patients who received information reported significantly fewer symptoms and scored significantly higher in the knowledge test. After controlling for confounding factors, patient education remains an additional predictor of BCRL outcome. Significantly fewer women who received information about BCRL reported swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling. Conclusions. Breast cancer survivors who received information about BCRL had significantly reduced symptoms and increased knowledge about BCRL. In clinical practice, breast cancer survivors should be engaged in supportive dialogues so they can be educated about ways to reduce their risk of developing BCRL.

UR - http://www.scopus.com/inward/record.url?scp=77954956905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954956905&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-0941-3

DO - 10.1245/s10434-010-0941-3

M3 - Article

VL - 17

SP - 1847

EP - 1853

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 7

ER -